Pneumococcal Vaccine for Adults (PCV)

Since October 2024 the CDC recommends pneumococcal vaccination for all adults aged 50 and older — down from 65. One dose of PCV20 or PCV21 completes the series for most people; PCV15 is followed by PPSV23 a year later.

Adult Vaccines — illustrative image
Adult Vaccines — illustrative image
Who it is forAll adults 50+; at-risk adults 19–49
Vaccine typeConjugate subunit (PCV15/20/21); PPSV23 is a polysaccharide vaccine — none are live
DosesUsually 1 dose of PCV20 or PCV21
Schedule sourceCDC pneumococcal recommendations, 2025

Pneumococcus causes pneumonia, bloodstream infection and meningitis, and older adults bear the highest risk of dying from it. For decades the age threshold for routine vaccination was 65; in October 2024 the CDC's advisory committee lowered it to 50, because disease rates climb from that age and vaccination at 50 protects through the highest-risk years.

The modern conjugate vaccines (PCV15, PCV20 and the adult-designed PCV21) link bacterial sugar coats to a protein for a stronger, longer-lasting response. Which product and how many doses you need depends on your age, risk factors and what you have already received — this guide covers the common situations; your clinician or pharmacist can check your exact record.

What this vaccine protects against

  • Pneumococcal pneumonia — the commonest serious pneumococcal illness in older adults.
  • Invasive pneumococcal disease: bloodstream infection and meningitis.
  • Disease in adults with chronic heart, lung, liver or kidney disease, diabetes, smoking, alcoholism, or weakened immunity.

Who should get it, and when

All adults aged 50 years and older who have never had a pneumococcal conjugate vaccine: 1 dose of PCV15, PCV20 or PCV21. If PCV20 or PCV21 is used, the series is complete — no PPSV23 is needed. If PCV15 is used, a dose of PPSV23 follows at least 1 year later.

Adults aged 19–49 with risk conditions — including chronic heart, lung, liver or kidney disease, diabetes, cigarette smoking, alcoholism, cochlear implants, cerebrospinal fluid leaks, and immunocompromising conditions — are also recommended vaccination; the product plan depends on the condition.

Adults 65 and older who completed an older series (PCV13 and PPSV23) have the option, through shared clinical decision-making, of one dose of PCV20 or PCV21.

Children under 5 have their own 4-dose PCV series — see the children's guide.

What happens at the vaccination visit

  • A single injection into the upper arm in most cases.
  • Bring any record of previous pneumonia vaccines (PCV13, PPSV23/'Pneumovax') — the right next step depends entirely on your history.

How to prepare

  • Ask the pharmacy or clinic to check your immunization record before the visit if you are unsure what you have had.
  • Tell the clinician about cochlear implants, spinal fluid leaks, spleen problems or immune suppression, which affect product choice and timing.

What to expect afterwards

A sore arm, redness and mild tiredness or low fever for a day or two are typical.

Reactions are usually milder than with the shingles vaccine and settle quickly.

Who should not get it, or should ask first

  • A severe allergic reaction to a previous pneumococcal vaccine (or, for PCV, to a diphtheria-toxoid-containing vaccine) is a contraindication — tell the clinician.
  • Moderate or severe illness is a reason to wait.
  • PCV and PPSV23 are not given at the same visit when both are part of a plan — the schedule spaces them.

Benefits

  • Reduces pneumococcal pneumonia and invasive disease in the age groups most likely to die from them.
  • For most adults vaccinated from 50, a single PCV20 or PCV21 dose completes the job — no series to track.

Limits and possible harms

  • Mostly brief local soreness; serious reactions are rare.
  • The vaccines cover the strains most associated with adult disease, not every pneumococcal strain, so pneumonia from other causes remains possible.

Useful links and tools

More in Adult Vaccines

Frequently asked questions

Why did the pneumococcal vaccine age change from 65 to 50?

In October 2024 the CDC's advisory committee voted to lower the routine age to 50, a change published in January 2025. Pneumococcal disease rates rise from age 50, and vaccinating then protects people through their 60s and beyond, when risk is highest.

I had a 'pneumonia shot' years ago. Do I need another?

Possibly — it depends which product you had and when. If you only had PPSV23 (Pneumovax), a conjugate vaccine dose is usually recommended at least 1 year later. If you already had PCV20 or PCV21, you are complete. Ask your clinician or pharmacist to review your record against the current CDC timing chart.

This guide explains how a vaccine is usually given and who it is generally offered to, following the CDC immunization schedules. It is general educational information only — not medical advice, and not a recommendation for you personally. Whether a vaccine is right for you depends on your age, health and history, so talk to your own clinician or pharmacist. If you are ill now, seek medical care promptly rather than waiting for a vaccination appointment.

← Adult Vaccines · Vaccines & Immunization home